MedTrace Logo

Systemic Right Ventricle Long-term Outcome

NCT06258083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 542

Last updated 2024-02-14

No results posted yet for this study

Summary

Patients with the transposition of great arteries (TGA) who undergo atrial switch operation and congenitally corrected TGA (ccTGA) patients have the right ventricle as their systemic ventricle. Function of the systemic right ventricle (SRV) could deteriorate which is associated with impaired prognosis. It is of paramount importance to understand the course and fate of these patients during a long-term follow-up to identify the determinants of adverse outcomes.

Conditions

  • Transposition of the Great Arteries
  • Systemic Right Ventricle

Sponsors & Collaborators

  • Hartekind

    collaborator UNKNOWN

  • Hartstichting

    collaborator UNKNOWN

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Joost P van Melle, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-26
Primary Completion
2023-08-24
Completion
2023-08-24

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06258083 on ClinicalTrials.gov